Global Competent Cells Market Size, Manufacturers, Opportunities and Forecast to 2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to 'shock' it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
According to APO Research, The global Competent Cells market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Competent Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
According to APO Research, The global Competent Cells market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
- Chemically Competent Cells
- Electrocompetent Cells
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Competent Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Competent Cells Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Competent Cells Market Size by Region (2019-2030)
1.4.1 Global Competent Cells Market Size by Region (2019-2024)
1.4.2 Global Competent Cells Market Size by Region (2025-2030)
1.5 Key Regions Competent Cells Market Size (2019-2030)
1.5.1 North America Competent Cells Market Size Growth Rate (2019-2030)
1.5.2 Europe Competent Cells Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Competent Cells Market Size Growth Rate (2019-2030)
1.5.4 Latin America Competent Cells Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Competent Cells Market Size Growth Rate (2019-2030)
2 COMPETENT CELLS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Chemically Competent Cells
2.1.2 Electrocompetent Cells
2.2 Global Competent Cells Market Size by Type
2.2.1 Global Competent Cells Market Size Overview by Type (2019-2030)
2.2.2 Global Competent Cells Historic Market Size Review by Type (2019-2024)
2.2.3 Global Competent Cells Market Size Forecasted by Type (2025-2030)
2.3 Global Competent Cells Market Size by Regions
2.3.1 North America Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Type (2019-2024)
3 COMPETENT CELLS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Subcloning & Routine Cloning
3.1.2 Phage Display Library Construction
3.1.3 Toxic/Unstable DNA Cloning
3.1.4 High-Throughput Cloning
3.1.5 Protein Expression
3.1.6 Mutagenesis
3.1.7 Single-Stranded DNA Production
3.1.8 Bacmid Creation
3.1.9 Cre-Lox Recombination (PIR1/PIR2)
3.2 Global Competent Cells Market Size by Application
3.2.1 Global Competent Cells Market Size Overview by Application (2019-2030)
3.2.2 Global Competent Cells Historic Market Size Review by Application (2019-2024)
3.2.3 Global Competent Cells Market Size Forecasted by Application (2025-2030)
3.3 Global Competent Cells Market Size by Regions
3.3.1 North America Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Competent Cells Industry Trends
4.2 Competent Cells Industry Drivers
4.3 Competent Cells Industry Opportunities and Challenges
4.4 Competent Cells Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Competent Cells Revenue (2019-2024)
5.2 Global Competent Cells Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Competent Cells Key Company Headquarters & Area Served
5.4 Global Competent Cells Company, Product Type & Application
5.5 Global Competent Cells Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Competent Cells Market CR5 and HHI
5.6.2 Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2023
5.6.3 2023 Competent Cells Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Merck KGaA
6.1.1 Merck KGaA Comapny Information
6.1.2 Merck KGaA Business Overview
6.1.3 Merck KGaA Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Merck KGaA Competent Cells Product Portfolio
6.1.5 Merck KGaA Recent Developments
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Comapny Information
6.2.2 Thermo Fisher Scientific Business Overview
6.2.3 Thermo Fisher Scientific Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments
6.3 Agilent Technologies
6.3.1 Agilent Technologies Comapny Information
6.3.2 Agilent Technologies Business Overview
6.3.3 Agilent Technologies Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Agilent Technologies Competent Cells Product Portfolio
6.3.5 Agilent Technologies Recent Developments
6.4 Takara Bio
6.4.1 Takara Bio Comapny Information
6.4.2 Takara Bio Business Overview
6.4.3 Takara Bio Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Takara Bio Competent Cells Product Portfolio
6.4.5 Takara Bio Recent Developments
6.5 Promega Corporation
6.5.1 Promega Corporation Comapny Information
6.5.2 Promega Corporation Business Overview
6.5.3 Promega Corporation Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Promega Corporation Competent Cells Product Portfolio
6.5.5 Promega Corporation Recent Developments
6.6 Beijing TransGen Biotech
6.6.1 Beijing TransGen Biotech Comapny Information
6.6.2 Beijing TransGen Biotech Business Overview
6.6.3 Beijing TransGen Biotech Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
6.6.5 Beijing TransGen Biotech Recent Developments
6.7 GeneScript Corporation
6.7.1 GeneScript Corporation Comapny Information
6.7.2 GeneScript Corporation Business Overview
6.7.3 GeneScript Corporation Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 GeneScript Corporation Competent Cells Product Portfolio
6.7.5 GeneScript Corporation Recent Developments
6.8 Yeastern Biotech
6.8.1 Yeastern Biotech Comapny Information
6.8.2 Yeastern Biotech Business Overview
6.8.3 Yeastern Biotech Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Yeastern Biotech Competent Cells Product Portfolio
6.8.5 Yeastern Biotech Recent Developments
6.9 New England Biolabs
6.9.1 New England Biolabs Comapny Information
6.9.2 New England Biolabs Business Overview
6.9.3 New England Biolabs Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 New England Biolabs Competent Cells Product Portfolio
6.9.5 New England Biolabs Recent Developments
6.10 QIAGEN N.V.
6.10.1 QIAGEN N.V. Comapny Information
6.10.2 QIAGEN N.V. Business Overview
6.10.3 QIAGEN N.V. Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 QIAGEN N.V. Competent Cells Product Portfolio
6.10.5 QIAGEN N.V. Recent Developments
6.11 OriGene Technologies
6.11.1 OriGene Technologies Comapny Information
6.11.2 OriGene Technologies Business Overview
6.11.3 OriGene Technologies Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 OriGene Technologies Competent Cells Product Portfolio
6.11.5 OriGene Technologies Recent Developments
6.12 Lucigen
6.12.1 Lucigen Comapny Information
6.12.2 Lucigen Business Overview
6.12.3 Lucigen Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Lucigen Competent Cells Product Portfolio
6.12.5 Lucigen Recent Developments
6.13 Zymo Research
6.13.1 Zymo Research Comapny Information
6.13.2 Zymo Research Business Overview
6.13.3 Zymo Research Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Zymo Research Competent Cells Product Portfolio
6.13.5 Zymo Research Recent Developments
6.14 Bio-Rad Laboratories
6.14.1 Bio-Rad Laboratories Comapny Information
6.14.2 Bio-Rad Laboratories Business Overview
6.14.3 Bio-Rad Laboratories Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
6.14.5 Bio-Rad Laboratories Recent Developments
6.15 Bioline
6.15.1 Bioline Comapny Information
6.15.2 Bioline Business Overview
6.15.3 Bioline Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Bioline Competent Cells Product Portfolio
6.15.5 Bioline Recent Developments
6.16 Delphi Genetics
6.16.1 Delphi Genetics Comapny Information
6.16.2 Delphi Genetics Business Overview
6.16.3 Delphi Genetics Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Delphi Genetics Competent Cells Product Portfolio
6.16.5 Delphi Genetics Recent Developments
6.17 IBA GmBH
6.17.1 IBA GmBH Comapny Information
6.17.2 IBA GmBH Business Overview
6.17.3 IBA GmBH Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 IBA GmBH Competent Cells Product Portfolio
6.17.5 IBA GmBH Recent Developments
6.18 Cell Applications
6.18.1 Cell Applications Comapny Information
6.18.2 Cell Applications Business Overview
6.18.3 Cell Applications Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Cell Applications Competent Cells Product Portfolio
6.18.5 Cell Applications Recent Developments
6.19 BioDynamics Laboratory
6.19.1 BioDynamics Laboratory Comapny Information
6.19.2 BioDynamics Laboratory Business Overview
6.19.3 BioDynamics Laboratory Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
6.19.5 BioDynamics Laboratory Recent Developments
6.20 Scarab Genomics
6.20.1 Scarab Genomics Comapny Information
6.20.2 Scarab Genomics Business Overview
6.20.3 Scarab Genomics Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Scarab Genomics Competent Cells Product Portfolio
6.20.5 Scarab Genomics Recent Developments
6.21 GCC Biotech
6.21.1 GCC Biotech Comapny Information
6.21.2 GCC Biotech Business Overview
6.21.3 GCC Biotech Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 GCC Biotech Competent Cells Product Portfolio
6.21.5 GCC Biotech Recent Developments
6.22 SMOBIO Technology
6.22.1 SMOBIO Technology Comapny Information
6.22.2 SMOBIO Technology Business Overview
6.22.3 SMOBIO Technology Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 SMOBIO Technology Competent Cells Product Portfolio
6.22.5 SMOBIO Technology Recent Developments
6.23 Edge BioSystems
6.23.1 Edge BioSystems Comapny Information
6.23.2 Edge BioSystems Business Overview
6.23.3 Edge BioSystems Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.23.4 Edge BioSystems Competent Cells Product Portfolio
6.23.5 Edge BioSystems Recent Developments
7 NORTH AMERICA
7.1 North America Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Competent Cells Market Size by Country (2019-2024)
7.3 North America Competent Cells Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Competent Cells Market Size by Country (2019-2024)
8.3 Europe Competent Cells Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Competent Cells Market Size by Country (2019-2024)
9.3 Asia-Pacific Competent Cells Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Competent Cells Market Size by Country (2019-2024)
10.3 Latin America Competent Cells Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Competent Cells Market Size by Country (2019-2024)
11.3 Middle East & Africa Competent Cells Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Competent Cells Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Competent Cells Market Size by Region (2019-2030)
1.4.1 Global Competent Cells Market Size by Region (2019-2024)
1.4.2 Global Competent Cells Market Size by Region (2025-2030)
1.5 Key Regions Competent Cells Market Size (2019-2030)
1.5.1 North America Competent Cells Market Size Growth Rate (2019-2030)
1.5.2 Europe Competent Cells Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Competent Cells Market Size Growth Rate (2019-2030)
1.5.4 Latin America Competent Cells Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Competent Cells Market Size Growth Rate (2019-2030)
2 COMPETENT CELLS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Chemically Competent Cells
2.1.2 Electrocompetent Cells
2.2 Global Competent Cells Market Size by Type
2.2.1 Global Competent Cells Market Size Overview by Type (2019-2030)
2.2.2 Global Competent Cells Historic Market Size Review by Type (2019-2024)
2.2.3 Global Competent Cells Market Size Forecasted by Type (2025-2030)
2.3 Global Competent Cells Market Size by Regions
2.3.1 North America Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Competent Cells Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Type (2019-2024)
3 COMPETENT CELLS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Subcloning & Routine Cloning
3.1.2 Phage Display Library Construction
3.1.3 Toxic/Unstable DNA Cloning
3.1.4 High-Throughput Cloning
3.1.5 Protein Expression
3.1.6 Mutagenesis
3.1.7 Single-Stranded DNA Production
3.1.8 Bacmid Creation
3.1.9 Cre-Lox Recombination (PIR1/PIR2)
3.2 Global Competent Cells Market Size by Application
3.2.1 Global Competent Cells Market Size Overview by Application (2019-2030)
3.2.2 Global Competent Cells Historic Market Size Review by Application (2019-2024)
3.2.3 Global Competent Cells Market Size Forecasted by Application (2025-2030)
3.3 Global Competent Cells Market Size by Regions
3.3.1 North America Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Competent Cells Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Competent Cells Industry Trends
4.2 Competent Cells Industry Drivers
4.3 Competent Cells Industry Opportunities and Challenges
4.4 Competent Cells Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Competent Cells Revenue (2019-2024)
5.2 Global Competent Cells Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Competent Cells Key Company Headquarters & Area Served
5.4 Global Competent Cells Company, Product Type & Application
5.5 Global Competent Cells Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Competent Cells Market CR5 and HHI
5.6.2 Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2023
5.6.3 2023 Competent Cells Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Merck KGaA
6.1.1 Merck KGaA Comapny Information
6.1.2 Merck KGaA Business Overview
6.1.3 Merck KGaA Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Merck KGaA Competent Cells Product Portfolio
6.1.5 Merck KGaA Recent Developments
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Comapny Information
6.2.2 Thermo Fisher Scientific Business Overview
6.2.3 Thermo Fisher Scientific Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments
6.3 Agilent Technologies
6.3.1 Agilent Technologies Comapny Information
6.3.2 Agilent Technologies Business Overview
6.3.3 Agilent Technologies Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Agilent Technologies Competent Cells Product Portfolio
6.3.5 Agilent Technologies Recent Developments
6.4 Takara Bio
6.4.1 Takara Bio Comapny Information
6.4.2 Takara Bio Business Overview
6.4.3 Takara Bio Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Takara Bio Competent Cells Product Portfolio
6.4.5 Takara Bio Recent Developments
6.5 Promega Corporation
6.5.1 Promega Corporation Comapny Information
6.5.2 Promega Corporation Business Overview
6.5.3 Promega Corporation Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Promega Corporation Competent Cells Product Portfolio
6.5.5 Promega Corporation Recent Developments
6.6 Beijing TransGen Biotech
6.6.1 Beijing TransGen Biotech Comapny Information
6.6.2 Beijing TransGen Biotech Business Overview
6.6.3 Beijing TransGen Biotech Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
6.6.5 Beijing TransGen Biotech Recent Developments
6.7 GeneScript Corporation
6.7.1 GeneScript Corporation Comapny Information
6.7.2 GeneScript Corporation Business Overview
6.7.3 GeneScript Corporation Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 GeneScript Corporation Competent Cells Product Portfolio
6.7.5 GeneScript Corporation Recent Developments
6.8 Yeastern Biotech
6.8.1 Yeastern Biotech Comapny Information
6.8.2 Yeastern Biotech Business Overview
6.8.3 Yeastern Biotech Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Yeastern Biotech Competent Cells Product Portfolio
6.8.5 Yeastern Biotech Recent Developments
6.9 New England Biolabs
6.9.1 New England Biolabs Comapny Information
6.9.2 New England Biolabs Business Overview
6.9.3 New England Biolabs Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 New England Biolabs Competent Cells Product Portfolio
6.9.5 New England Biolabs Recent Developments
6.10 QIAGEN N.V.
6.10.1 QIAGEN N.V. Comapny Information
6.10.2 QIAGEN N.V. Business Overview
6.10.3 QIAGEN N.V. Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 QIAGEN N.V. Competent Cells Product Portfolio
6.10.5 QIAGEN N.V. Recent Developments
6.11 OriGene Technologies
6.11.1 OriGene Technologies Comapny Information
6.11.2 OriGene Technologies Business Overview
6.11.3 OriGene Technologies Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 OriGene Technologies Competent Cells Product Portfolio
6.11.5 OriGene Technologies Recent Developments
6.12 Lucigen
6.12.1 Lucigen Comapny Information
6.12.2 Lucigen Business Overview
6.12.3 Lucigen Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Lucigen Competent Cells Product Portfolio
6.12.5 Lucigen Recent Developments
6.13 Zymo Research
6.13.1 Zymo Research Comapny Information
6.13.2 Zymo Research Business Overview
6.13.3 Zymo Research Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Zymo Research Competent Cells Product Portfolio
6.13.5 Zymo Research Recent Developments
6.14 Bio-Rad Laboratories
6.14.1 Bio-Rad Laboratories Comapny Information
6.14.2 Bio-Rad Laboratories Business Overview
6.14.3 Bio-Rad Laboratories Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
6.14.5 Bio-Rad Laboratories Recent Developments
6.15 Bioline
6.15.1 Bioline Comapny Information
6.15.2 Bioline Business Overview
6.15.3 Bioline Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Bioline Competent Cells Product Portfolio
6.15.5 Bioline Recent Developments
6.16 Delphi Genetics
6.16.1 Delphi Genetics Comapny Information
6.16.2 Delphi Genetics Business Overview
6.16.3 Delphi Genetics Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Delphi Genetics Competent Cells Product Portfolio
6.16.5 Delphi Genetics Recent Developments
6.17 IBA GmBH
6.17.1 IBA GmBH Comapny Information
6.17.2 IBA GmBH Business Overview
6.17.3 IBA GmBH Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 IBA GmBH Competent Cells Product Portfolio
6.17.5 IBA GmBH Recent Developments
6.18 Cell Applications
6.18.1 Cell Applications Comapny Information
6.18.2 Cell Applications Business Overview
6.18.3 Cell Applications Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Cell Applications Competent Cells Product Portfolio
6.18.5 Cell Applications Recent Developments
6.19 BioDynamics Laboratory
6.19.1 BioDynamics Laboratory Comapny Information
6.19.2 BioDynamics Laboratory Business Overview
6.19.3 BioDynamics Laboratory Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
6.19.5 BioDynamics Laboratory Recent Developments
6.20 Scarab Genomics
6.20.1 Scarab Genomics Comapny Information
6.20.2 Scarab Genomics Business Overview
6.20.3 Scarab Genomics Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Scarab Genomics Competent Cells Product Portfolio
6.20.5 Scarab Genomics Recent Developments
6.21 GCC Biotech
6.21.1 GCC Biotech Comapny Information
6.21.2 GCC Biotech Business Overview
6.21.3 GCC Biotech Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 GCC Biotech Competent Cells Product Portfolio
6.21.5 GCC Biotech Recent Developments
6.22 SMOBIO Technology
6.22.1 SMOBIO Technology Comapny Information
6.22.2 SMOBIO Technology Business Overview
6.22.3 SMOBIO Technology Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 SMOBIO Technology Competent Cells Product Portfolio
6.22.5 SMOBIO Technology Recent Developments
6.23 Edge BioSystems
6.23.1 Edge BioSystems Comapny Information
6.23.2 Edge BioSystems Business Overview
6.23.3 Edge BioSystems Competent Cells Revenue, Global Share and Gross Margin (2019-2024)
6.23.4 Edge BioSystems Competent Cells Product Portfolio
6.23.5 Edge BioSystems Recent Developments
7 NORTH AMERICA
7.1 North America Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Competent Cells Market Size by Country (2019-2024)
7.3 North America Competent Cells Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Competent Cells Market Size by Country (2019-2024)
8.3 Europe Competent Cells Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Competent Cells Market Size by Country (2019-2024)
9.3 Asia-Pacific Competent Cells Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Competent Cells Market Size by Country (2019-2024)
10.3 Latin America Competent Cells Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Competent Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Competent Cells Market Size by Country (2019-2024)
11.3 Middle East & Africa Competent Cells Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
